Fertility Market Report The latest innovations in the market

The fertility testing market is projected to grow significantly over the projected period 2021-2031, thanks to rising first-age pregnancies, declining fertility rates worldwide, a growing number of women suffering from PCOS, and technological advances such as IVF and IUI. There are many fertility tests for men and women. Male fertility tests include semen analysis, hormone testing, genetic testing, testicular biopsy, imaging, and other special tests that try to examine if the genitals are damaged. Female fertility relies on the ovaries, reproductive tract, uterus, and thus attempts are made to determine whether any of these processes are damaged. Fertility test for women includes ovulation testing, ovarian reserve testing, hysterosalpingography, imaging tests, etc. All of these tests depend on the person’s condition.

Increasing the age of pregnancy to increase demand

According to medical science, a woman’s peak reproductive age is between late teens and 30. After the age of 30 or 32, fertility begins to decline. The number of eggs in women begins to decrease as they age, and it is also more likely that eggs in older women will have abnormal chromosomes, so with age there is a higher risk of disorders that can affect fertility such as uterine fibroids and endometriosis. Couples today are planning a late pregnancy. The average age of women in their first pregnancy increased from 28.8 years in 2013 to 29 to 30 years. In America, women plan to become pregnant at the age of 31, for many reasons such as financial reasons, career and life goals, etc. The age-increasing factor can lead to more fertility tests, which increases demand.

Get a report brochure @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7386

Increasing use of in vitro fertilization

In vitro fertilization treatment is an effective form of reproductive technology. In vitro fertilization can be performed using the eggs and sperm of a partner or a known or unknown donor. As the embryo is implanted in a woman’s uterus, the procedure seems convenient and adaptable. More than 8 million babies have been born from in vitro fertilization since 1978 in Europe. The IVF procedure is used when other fertility treatments do not work. It increases the chances of getting a healthy baby even after a certain age and can be used by anyone.

Less precise ovulation test kits

Ovulation test kits work until a certain age. It may not work consistently for women over the age of 40, especially if they are approaching menopause. As women approaching menopause increase the level of LH in their systems at any time, which makes the test invalid. In addition, if certain fertility drugs are present in the system, then ovulation testing kits may not work accurately. Therefore, as a test kit, it can create an impediment to growth.

High cost of fertility testing

Ovulation kits and other fertility kits are not very cheap. The price also depends on the brand and its popularity. Due to the high cost of these fertility test kits and monitors, developing countries can keep and limit the amount if people can afford it.

Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=7386

Competitive landscape

Prominent market players include Swiss Precision Diagnostics (Switzerland), Prestige Brands Holdings (USA), Geratherm Medical (Germany), AdvaCare Pharma (USA), UEBE Medical (Germany), AVA (Switzerland), Mira Care (USA), Fertility Focus Ltd. (UK), Hilin Life Products (USA), Babystart (UK), Church & Dwight (USA), Valley Electronics (Germany), TaiDoc Technology Corporation, Fairhaven Health, LLC, Quidel Corporation, etc.

Ovusense teamed up with Exseed, an in-house sperm testing company, in February 2021, as a complete solution for the couple. Together, companies provide couples with the best chances of conceiving and assure that they can know they can achieve a successful pregnancy. Together, the two companies provide day-to-day insights into fertility through an added offering of best-in-class clinically proven medical surveillance that allows couples to share data and work with their specialists remotely. The company has launched the app given the covid-19 situation.

Researchers are also focusing on new achievements such as the Association of Reproductive and Clinical Scientists founded in 2020 by merging three individual professional societies, namely the Association of Clinical Embryologists, the Association of Biomedical Andrologists and the British Andrological Society for Advancing Reproductive Science through Training and Education. ARCS have their own CPD program with reviews and certificates assigned to their members. The association provides research and development in the reproductive sciences, IVF technology, digital technology, embryo development, etc.

In June 2020, Modern Fertility launched pregnancy and ovulation tests and a mobile app. One test is for detecting pregnancy, and the other for ovulation in order to stand out from the competition. The app helps in reading and tracking test results, which is a broader effort by the company to shift the fertility category to the usual wellness. The company’s application provides a specific value of luteinizing hormone that leads to ovulation and monitors its level overtime, and does not simply give a yes or no in response.

Regional Outlook

North America is expected to occupy the largest market share in fertility testing. Increasing awareness of fertility tests, increasing the age of first pregnancies, easy availability of fertility monitors are likely to adopt fertility kits. According to a 2020 CDC report, U.S. births continue to fall, and overall fertility rates have also declined since 2007. The U.S. recorded nearly 3.75 births in 2019, down 1% from 2018 The birth rate also declined for women in their 20s and 30s, but rose for women in their 40s, necessitating fertility tests and market growth.

The Asia-Pacific region is expected to project the fastest growth in fertility testing thanks to growing demand for stand-alone and rapid tests. As the Asian region is a region with 60% of the world’s youth, the market is likely to increase. Investments in the medical industry in Asia, lifestyle disorders in men and women, the increasing frequency of couples opting for in vitro fertilization or surrogacy are the main factors growing in the fertility testing market. As South Korea is one of the countries with economical medical procedures, increasing medical tourism paves the way for greater investment. In South Korea, Japan and Singapore, governments offer subsidies in infertility treatment costs due to low birth rates.

In European countries, the average age has increased in all EU member states. In Estonia, the average age has increased by 1.2 years since 2013. In Spain, women were 31.0 years old during their first pregnancy, in Italy 30.9 years, Ireland 30.5 years, Luxembourg 30.9 years, Greece 30, 4 years of age. The increasing age of women can lead to a high chance of conducting fertility tests. Furthermore, cases of infertility are growing among various European countries, lifestyle changes with increasing infertility disorders in both men and women are increasing the demand for fertility testing in the region.

Get report content @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7386

Segmentation

Based on the product

  • Ovulation prediction kits
  • Fertility monitors
  • Male fertility testing products

Based on the application

  • Products of male fertility
  • Products of female fertility

Based on the sample

Based on the purchase

  • Based on the recipe
  • OTC based
  • Online products

Based on the end user

  • Home care settings
  • Hospitals
  • Fertility clinics

Based on the region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Answer key questions

  • Who are the leading players in the market?

Prestige Brands Holdings (USA), Geratherm Medical (Germany), AdvaCare Pharma (USA), UEBE Medical (Germany), AVA (Switzerland), Mira Care (USA), etc.

  • For which end-user segment is growth projected over the forecast period?

Setting up home care attributing to Covid-19 and remote processing.

  • In which region will the largest market share of fertility tests be held?

North America is expected to have a dominant share.

  • Based on the application, for which segment is growth expected during the forecast period?

The segment of female fertility testing is expected to increase due to an increase in the declining fertility rate of women.

  • What are the types of fertility testing products?

Fertility monitors, ovulation prediction kits, male fertility testing products.

About TMR research

TMR Research is a leading provider of custom market research services and consulting services to businesses looking to succeed in today’s excessive economic climate. Armed with an experienced, dedicated and dynamic team of analysts, we redefine the way our clients do business by providing them with authoritative and reliable research studies in line with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: + 1-415-520-1050

Visit the page: https://www.tmrresearch.com/

.Source